The regulation of the phospholipase C (PLC) and the expression of inositol 1,4,5-trisphosphate receptors (IP 3 Rs) in terms of mRNA, proteins, and binding capacity were examined in the rat myometrium and endometrium at midgestation (Day 12) and at term (Day 21) comparatively to the estrogen-treated tissues (Day 0). In both uterine tissues, the production of inositol phosphates mediated by carbachol as well as by AlF 4 Ϫ was enhanced with advancing gestation. 
INTRODUCTION
The uterus undergoes remarkable changes in growth and function during pregnancy. The biochemical and morphological changes that take place in the endometrium are thought to be a prerequisite for implantation and adequate development of the fetus. The function of the myometrium gradually changes during gestation. It is initially quiescent so as to maintain the growing fetus and then becomes active at term to expel the mature fetus. Cellular processes as diverse as cell motility, contraction, secretion, and cell proliferation are regulated by intracellular Ca 2ϩ [1, 2] , and this may be of crucial importance for uterine cells during gestation. The initial response of many cells to Ca 2ϩ -mobilizing receptor agonists is the activation of phospholipase C (PLC) catalyzing the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) leading to an increase in inositol 1,4,5-trisphosphate (IP 3 ) production [3] . It is known that the generation of IP 3 and the associated increase in intracellular Ca 2ϩ concentration is an important determinant of smooth muscle contractility [4] . Stimulation of the phosphoinositide-PLC pathway by contractile agonists that activate Gprotein-coupled receptors has been demonstrated in various myometrial preparations [5] [6] [7] [8] [9] .
IP 3 binds to an intracellular IP 3 receptor (IP 3 R) located on the surface of intracellular Ca 2ϩ stores, e.g., endoplasmic reticulum, and then releases Ca 2ϩ into the cytoplasm [1, 10] . Thus, the IP 3 R plays a central role in the conversion of IP 3 signals produced by external stimuli into intracellular Ca 2ϩ signals. Molecular cloning studies have demonstrated the existence of at least three types of IP 3 Rs, encoded by genes designated type 1 [11, 12] , type 2 [13] , and type 3 [14] . These three IP 3 R types have different primary structures and tissue distributions, and their amino acid sequences are approximately 60-70% identical. IP 3 Rs also differ in their affinity for IP 3 , in the order IP 3 R-2 Ͼ IP 3 R-1 Ͼ IP 3 R-3 [15] .
We have recently shown that, in rat myometrium, the responsiveness of the PLC␤ 3 pathway associated with receptor and/or direct G-protein activation increased during gestation and coincided with the increase in the amount of G q /G 11 [8] . Little is known about the IP 3 receptor isoforms present in the rat uterus and their possible regulation in relation to pregnancy and increases in the production of inositol phosphates. We addressed this question by assessing IP 3 binding capacity and the expression of IP 3 R isoform genes in terms of mRNA and corresponding protein levels in the myometrium and endometrium at the middle (Day 12) and end (Day 21) of gestation compared to estrogenprimed rats (Day 0). We found that 1) the number of IP 3 binding sites increased in both tissues with advancing gestation; 2) IP 3 R-1, -2, and -3 genes were coexpressed, albeit to different extents, in the nonpregnant myometrium and endometrium; and 3) the expression of IP 3 R-1 and IP 3 R-3 increased over the course of gestation, whereas the level of IP 3 R-2 increased only in the endometrium at term. 
MATERIALS AND METHODS

Materials
Animals and Tissue Processing
Pregnant rats (Wistar) were used at Days 12 and 21 of gestation. Immature female rats (Wistar 5 wk old) were treated with 30 g estradiol for 2 days and were used the following day. These estradiol-primed animals were considered as Day 0. Rats were killed by decapitation, and the uterine horns were quickly cleared of adhering fat and excised out longitudinally. After removal of fetuses, their sites of attachment, and placental tissues, myometrium was separated by stripping away the endometrium as previously described [5, 8] . Histological sections of myometrial preparations showed the samples to consist almost exclusively of longitudinal muscle. For each specific experiment we minimized variation by using tissues pooled from uteri from at least 12 (Day 0), 6 (Day 12), and 3 (Day 21) rats.
Determination of [ 3 H]Inositol Phosphates
Myometrial and endometrial strips (ϳ30 mg) were labeled with 5 Ci of myo-[ 3 H]inositol (0.4 M) [5, 8] . Tissues were washed three times with nonradioactive Krebs buffer and were incubated with 1 ml of fresh buffer, containing 10 mM LiCl before exposure to the agents indicated. Reactions were stopped by immersing the strips in 1.5 ml of cold 7% (w:v) trichloroacetic acid (TCA), followed by homogenization and centrifugation at 3000 ϫ g for 20 min at 4ЊC. The TCA-soluble supernatants were extracted with diethylether, neutralized with Tris base, and applied to a column (0.7 ϫ 2 cm) of anion-exchange AG1-X8. Total inositol phosphates (IP 3 ϩ IP 2 ϩ IP 1 ) were eluted together in a single step with 12 ml of 1 M ammonium formate/0.1 M formic acid. The [ 3 H]phosphoinositides present in the TCA pellets were extracted by the method of Bligh and Dyer [17] , essentially as previously described [6] . The 3 H content of the various samples was determined by scintillation spectrometry. The production of [ 3 H]inositol phosphates was expressed as a percentage of radioactivity incorporated into phosphoinositides obtained from the corresponding sample.
Western Blot Analysis
Endometrial and myometrial membranes were prepared as previously described [8] and stored at Ϫ80ЊC. Protein concentration was determined by the method of Bradford [18] . Protein samples were analyzed by SDS-PAGE in 5% acrylamide gels as described by Laemmli [19] , and the proteins were then transferred to Hybond-ECL membranes that were then blocked 60 min in 5% nonfat dried milk in Trisbuffered saline (TBS; 20 mM Tris-HCl, pH 7.5, 500 mM NaCl). The blots were probed with rabbit polyclonal anti-IP 3 R-1 antibody or rabbit polyclonal antibody against a synthetic peptide corresponding to the 16 C-terminal residues of IP 3 R-2 [16] , both used at 1:1000 dilution. Monoclonal antibody against IP 3 R-3 was used at 1:2000 dilution. The primary antibodies against IP 3 R-1 and IP 3 R-2 were detected with an antirabbit IgG antibody coupled to horseradish peroxidase, and the primary antibody against IP 3 R-3 was detected with an antimouse IgG antibody (dilution 1: 5000), using the ECL detection system. In certain experiments, the blots were reprobed after stripping in 62.5 mM Tris-HCl, pH 6.7, 2% SDS, and 100 mM ␤-mercaptoethanol for 60 min at 60ЊC. Nitrocellulose sheets were rinsed in TBS and then reblotted for 60 min in 5% nonfat dried milk in TBS before being sequentially probed with other antibodies. The developed blots were quantified by densitometry with a Molecular Dynamics Densitometer. We verified that the amplitude of the signal was proportional to the amount of proteins loaded on the gels, at least within the investigated range (10-50 g). Thus, the binding of primary and secondary antibodies as well as the ECL reaction were not limiting.
Equilibrium [ 3 H]IP 3 Binding Studies
For IP 3 binding studies, the myometrial and endometrial membrane fractions (300 g) were incubated for 6 min on ice in 500 l of ice-cold cytosol-like medium consisting of 110 mM KCl, 20 mM NaCl, 1 mM Na 2 HPO 4 , 1 mM EDTA, 25 mM HEPES/KOH, pH 7.5, supplemented with 1 mg/ml BSA and 1 nM [ 3 H]IP 3 (20 Ci/mmol), with or without unlabeled IP 3 , to give a final concentration of 1, 5, and 50 nM, as previously described [16, 20] . Nonspecific binding was determined in the presence of 5 M IP 3 . At the end of incubation, 400 l of the sample was layered onto a Whatman GF/C glass-fiber filter and washed with 1 ml of ice-cold medium containing 250 mM sucrose, 10 mM Na 2 HPO 4 , at pH 8. Radioactivity retained on the filter was counted by scintillation spectrometry. IP 3 binding was expressed in each sample as femtomoles per milligram of protein.
cDNA Probes and Northern Blot Analysis IP 3 R-1 was detected with a 2.5-kilobase (kb) probe [12] , obtained by digestion with BamHI (4126-6658) of the fulllength rat cDNA encoding type 1 IP 3 R (pCMVI-9). IP 3 R-2 was detected with a 1.7-kb probe [13] obtained by digestion with BamHI and PstI (1804-3475) of the rat type 2 partial cDNA (pCMVI-102). IP 3 R-3 was detected with a 1.9-kb probe [14] obtained by digestion with SacI (5247-7143) of the corresponding rat cDNA (pCBGϩIP 3 R-3). Probes were 32 P-labeled with the Megaprime DNA labeling kit.
Total RNA was extracted from isolated uterine tissues using the RNeasy Mini Kit and QIAshredder columns, according to the manufacturer's protocols. Samples of total RNA were denatured in 1 mM glyoxal [21] and fractionated by electrophoresis in 1% agarose gels. The RNA was then transferred to Hybond-N membranes and probed with the 32 P-labeled cDNA fragments as described elsewhere [21] . The membranes were washed in high-stringency conditions with a final 15-min wash in 0.1ϫ standard saline citrate/ 0.1% SDS at 60ЊC. Radioactivity in the membrane was quantified with a PhosphoImager scanner using Imagequant 3.2 software (both from Molecular Dynamics) before the membrane was placed against x-ray film. RNA levels were standardized by reprobing the blots with 18S rRNA probes. 
Data Analysis
The results are expressed as means Ϯ SEM. Means were compared using Student's t-test. P Ͻ 0.05 was considered to be significant.
RESULTS
Increase in the Generation of [ 3 H]Inositol Phosphates in Rat Myometrium and Endometrium During Gestation
We have previously demonstrated that pregnancy leads to a marked enhancement in phosphoinositide breakdown with an increased production of IP 3 in rat myometrium [8] . We found in this study that this is also the case for the endometrium (Table 1 ). In both myometrial and endometrial preparations, there was a basal level of inositol phosphates generation. Inositol phosphate levels were two and three times higher at Days 12 and 21, respectively, than at Day 0 for both tissues. Similarly, the induction by carbachol (100 M) of inositol phosphate production increased during gestation (Day 21 Ͼ Day 12 Ͼ Day 0). At this concentration (100 M), the muscarinic agonist caused a maximal inositol phosphate response in both tissues (data not shown). The pattern of the increase in inositol phosphate generation (Day 21 Ͼ Day 12 Ͼ Day 0) was similar if the stimulation was triggered by AlF 4 Ϫ , a direct activator of G-proteins. 
Pregnancy-Related Expression of IP 3 R Proteins in Rat Myometrium and Endometrium
We used specific IP 3 R-1, IP 3 R-2, or IP 3 R-3 antibodies to investigate the expression and possible quantitative changes in these receptors in rat myometrium and endometrium during gestation. We performed immunoblots with myometrial and endometrial membranes derived from various stages of gestation (0, 12, and 21 days), resolved by SDS-PAGE, and stained with specific antibodies (Fig. 1) . The three types of IP 3 R, all about 260 kDa in size, were present at day 0 and throughout gestation in both uterine tissues. Quantitative analysis of various blots indicated that IP 3 R-1 was more strongly expressed (3.8 times higher levels, n ϭ 3, P Ͻ 0.01) in myometrial than in endometrial membranes for Day 0 rats. IP 3 R-1 levels were higher in both tissues during pregnancy than at Day 0. In the myometrium, IP 3 R-1 protein levels were 1.5 and 3 times higher at Days 12 and 21, respectively, than at Day 0 (n ϭ 3, P Ͻ 0.01). In the endometrium IP 3 R-1 levels were 3 and 7 times higher at Days 12 and 21, respectively than at Day 0 (n ϭ 3, P Ͻ 0.01). IP 3 R-2 was detected in both myometrium and endometrium. The level of expression of this isoform did not change during pregnancy in the myometrium but was upregulated (2 times higher, n ϭ 3, P Ͻ 0.01) at term in the endometrium. IP 3 R-3 levels were upregulated during pregnancy in both endometrium and myometrium (2 and 4 times higher at Days 12 and 21, respectively, than at Day 0, n ϭ 3, P Ͻ 0.01). The IP 3 R-3 isoform was preferentially expressed in the endometrium. The above quantitative variations could be observed for different amounts of proteins up to 50 g. Additionally, when the blots (Fig. 1) were reprobed with antibodies specific to calreticulin, a calcium-related protein, the immunologic signal remained identical for all myometrial and endometrial preparations, reflecting that the changes observed were specific for IP 3 Rs (data not shown). Thus, in both the myometrium and the endometrium, the three types of IP 3 R are expressed but are differentially regulated during the course of gestation.
Pregnancy-Related Expression of IP 3 R mRNA in Rat Myometrium and Endometrium
We assessed the amount of mRNA present for each type of IP 3 R by Northern blotting using specific probes obtained from the respective cDNAs cloned from rats (Fig. 2) . Northern blots were carried out with 25 g of total RNA from myometrium or endometrium obtained from Day 0 rats or from pregnant rats at Days 12 and 21 of gestation. We detected a single ϳ10-kb transcript for each type of IP 3 R. IP 3 R-1 mRNA levels at Day 0 were 4 times lower in the endometrium than in the myometrium (n ϭ 3, P Ͻ 0.01). The pattern of IP 3 R-1 mRNA expression during gestation differed in myometrium and endometrium. In the myometrium, IP 3 R-1 mRNA levels were 3 times higher (n ϭ 3, P Ͻ 0.01) at midgestation than Day 0 levels, and decreased to Day 0 levels at Day 21. However, in the endometrium, IP 3 R-1 mRNA expression increased progressively throughout gestation, with levels 4 times higher at Day 21 than at Day 0 (n ϭ 3, P Ͻ 0.01). IP 3 R-2 mRNA expression was barely detectable in Day 0 myometrium, with no apparent change at Days 12 and 21. In the endometrium, IP 3 R-2 mRNA levels were very low at Day 0 but consistently increased and were 2.5 times higher at the end of gestation (n ϭ 3, P Ͻ 0.01). The IP 3 R-3 isoform was detected in both myometrium and endometrium. At Day 0, the level of mRNA for this isoform in the endometrium was twice that in the myometrium, and the level of this mRNA progressively increased in both tissues during gestation, being 3 times higher at Day 21 (n ϭ 3, P Ͻ 0.01).
DISCUSSION
We have previously reported that there is a progressive increase during gestation in the generation of inositol phosphates triggered by receptor and G-protein activation in the rat myometrium [8] . We demonstrate herein that the PIP 2 / PLC signaling pathway is similarly upregulated in the endometrium throughout pregnancy (Day 21 Ͼ Day 12 Ͼ Day 0). In both uterine tissues, the higher levels of inositol phosphates at Days 12 and 21 of gestation were associated with an increase in the capacity for binding IP 3 to its receptors on the corresponding membrane preparations. Northern blot hybridization experiments demonstrated the presence in the myometrium and endometrium of three different mRNAs encoding for the three IP 3 R (IP 3 R-1, -2, and -3) isoforms. Immunoblot experiments with isoform-specific antibodies confirmed the presence of IP 3 R-1, -2, and -3 proteins in both the myometrium and endometrium. The expression IP 3 R-1 and IP 3 R-3 increased during the course of gestation in both tissues, whereas the expression of IP 3 R-2 increased only in the endometrium at term. There was a strong correlation between the levels of mRNA and protein except for IP 3 R-1 in the myometrium. IP 3 R-1 mRNA levels peaked at Day 12 and then declined at Day 21, whereas the corresponding protein level increased progressively (Day 21 Ͼ Day 12 Ͼ Day 0). Such a lack of correlation between mRNA and protein levels may reflect differences in half-time degradation for mRNA and proteins. IP 3 R-1 appeared to be expressed preferentially in the myometrium, whereas IP 3 R-3 levels were higher in the endometrium, and IP 3 R-2 was poorly expressed in the myometrium as compared to the endometrium. These differences between the two uterine tissues suggest that IP 3 receptor isoforms have different cell-specific functions.
Several uterine functions are regulated during gestation. These include the cell proliferation that is associated with the hyperplasia of both uterine tissues, active cell death that increases as pregnancy progresses, the secretory function of the epithelial cells of the endometrium that contribute to the output of key regulatory factors necessary for the initiation and maintenace of pregnancy, and finally the coordinated muscle contraction needed to expel the fetus. All these functions are controlled by an increase in the cytosolic Ca 2ϩ concentration in the target cells. The variety of the spatiotemporal pattern of the Ca 2ϩ signaling has been implicated in this versatility of Ca 2ϩ -regulated functions. The frequency and the amplitude of the Ca 2ϩ oscillations can be decoded to allow specific gene expression [22] . Using cell-permeant caged IP 3 ester, it was shown that Ca 2ϩ spike frequency can optimize gene expression [23] or efficient activation of calmodulin-dependent protein kinase II [24] . Recent work demonstrated that specific Ca 2ϩ signaling patterns can be encoded by differential expression of IP 3 R subtypes [25] . Smooth muscle contraction is generally thought to be activated by IP 3 -induced Ca 2ϩ release from sarcoplasmic reticulum [1, 4] . Because IP 3 R-1 levels are highest in the myometrium, it is likely that the type 1 IP 3 R may be one of the suppliers of the Ca 2ϩ required for activation of uterine contractions. This interpretation is supported by the upregulation of IP 3 R-1 levels at midpregnancy, culminating near term. The simultaneous increase in IP 3 generation and IP 3 R-1 expression near term may be of physiological relevance because this would make it possible for the myometrial cells to produce the appropriate coordinated contractions needed to expel the fetus. Worth considering are the reports demonstrating high levels of IP 3 R-1 in human [26] and mouse [27] myometrium. IP 3 R-3 is expressed and upregulated (Day 21 Ͼ Day 12 Ͼ Day 0) in both endometrial and myometrial cells. A potential role for IP 3 R-3 in the Ca 2ϩ regulation of myometrial contractility can similarly be retained. Ca 2ϩ is also known to play a key role in smooth muscle cell proliferation, so it was not surprising that the amounts of uterine IP 3 receptors, mainly types 1 and 3, increased during gestation, which is associated with the proliferation and hyperplasia of both uterine tissues. The IP 3 R-2 receptor was hardly detectable in the myometrium at Day 0 and throughout gestation; it was expressed in the endometrium where it was up-regulated at term, suggesting a functional role for this type of IP 3 receptor in the endometrium but its minimal role in controlling myometrial activites.
Pregnancy-related changes in the PLC signaling cascade in rat myometrium, operating at the level of G q /G 11 have been reported [8] . This study demonstrates that the IP 3 receptor system is a further example of a key signaling component of the PLC pathway whose expression and binding capacities are affected by the hormonal status of the uterus. The increased amounts of IP 3 receptors and their mRNA levels in uterine tissues are probably due to changes in the estrogen/progesterone balance occurring during gestation. A potential regulation of the expression of IP 3 receptors by sex steroid hormones can thus be postulated. In line with this proposal is the recent report demonstrating the presence of a steroid element on the promotor of the gene for IP 3 R-1 [28] . It has also recently been reported that in addition to sex steroids, the mechanical stretch imparted by the growing uterine content may contribute to differential control of gene expression in the pregnant uterus [29] . Our data concerning the differential expression of IP 3 R in the endometrium and myometrium may allow the encoding of a different spatiotemporal pattern of Ca 2ϩ signaling in the uterine cell types, resulting in the ultimate control of specific processes that occur in the uterus during gestation.
